Innovative Showcase at BIO-Europe 2024
Tsingke proudly concluded its participation in BIO-Europe 2024, a premier global gathering for the biotechnology and pharmaceutical sectors. The event attracted over 5,500 attendees representing more than 2,800 companies from over 60 countries, uniting industry leaders and experts to discuss the future of biotechnology.
Driving Synthetic Biology
At this event, Tsingke highlighted its cutting-edge offerings in synthetic biology, showcasing a variety of innovative products and services at Booth #174 B. Their showcase included synthesis services, self-developed synthetic materials, bioreagents, consumables, and state-of-the-art equipment. Tsingke's commitment is to reshape research and enhance life science through advanced technologies.
A Hub for Partnerships
The booth attracted significant attention, with industry professionals actively engaging with Tsingke's team. Many visitors explored potential collaborations that could speed up research efforts and overcome complex challenges in areas like gene therapy, diagnostics, and bio-manufacturing.
Highlighting Cutting-Edge Products
Gene Synthesis: Tsingke leads in intelligent gene synthesis, offering high-quality and efficient plasmid production. Their services support plasmid sizes up to 200kb and cater to over 160 commercial vectors. Customers benefit from complimentary codon optimization and can expect a turnaround time of just 5 days, along with meticulous NGS and Sanger sequencing for quality assurance.
Oligo Synthesis: Tsingke provides high-quality oligos, ensuring 99.5% coupling efficiency through stringent quality control processes. Their offerings also include custom RNA oligos, meeting the highest purity standards and equipped with GMP-compliant facilities.
Protein Expression: Tsingke's extensive protein expression services cover sequence design through to purification, utilizing various expression systems like E. coli and mammalian cells. Their fast delivery and expert support ensure customer satisfaction, making them a trusted partner in research endeavors.
Commitment to Innovation
Beijing Tsingke Biotech Co., Ltd. is dedicated to advancing the field of DNA and RNA synthesis, leveraging an advanced synthesis platform that includes gene synthesis, antibody production, and more. Tsingke's commitment to quality and customer engagement sets them apart in the industry.
As BIO-Europe 2024 concludes, Tsingke remains focused on fostering innovation in synthetic biology. The company is eager to engage with partners worldwide, driving progress in biotechnology and seeking collaborative opportunities to advance scientific research.
Frequently Asked Questions
What is Tsingke's focus at BIO-Europe 2024?
Tsingke focused on showcasing its cutting-edge innovations in synthetic biology, including gene synthesis and protein expression.
Why is Tsingke's booth significant?
The booth served as a hub for potential collaborations, attracting professionals from various sectors eager to understand Tsingke's solutions.
How does Tsingke ensure quality in its products?
Tsingke implements stringent quality control measures throughout production, ensuring high-quality outputs for their clients.
What collaborative areas does Tsingke explore?
Tsingke collaborates on projects related to gene therapy, diagnostics, and bio-manufacturing, among others.
What is Tsingke's mission moving forward?
Tsingke aims to drive innovation and collaboration in the synthetic biology field, enhancing research capabilities globally.
